Jeffrey Thomas Perez
Net Worth

Last updated:

What is Jeffrey Thomas Perez net worth?

The estimated net worth of Mr. Jeffrey Thomas Perez is at least $8,041,803 as of 5 Apr 2024. He owns shares worth $1,422,599 as insider, has earned $267,724 from insider trading and has received compensation worth at least $6,351,480 in Precigen, Inc..

What is the salary of Jeffrey Thomas Perez?

Mr. Jeffrey Thomas Perez salary is $705,720 per year as Senior Vice President of Intellectual Property Affairs in Precigen, Inc..

How old is Jeffrey Thomas Perez?

Mr. Jeffrey Thomas Perez is 53 years old, born in 1972.

What stocks does Jeffrey Thomas Perez currently own?

As insider, Mr. Jeffrey Thomas Perez owns shares in one company:

Company Title Shares Price per share Total value
Precigen, Inc. (PGEN) Senior Vice President of Intellectual Property Affairs 458,903 $3.1 $1,422,599

What does Precigen, Inc. do?

Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorporates advanced DNA construction technologies and computational models to design and assemble genetic components into complex gene expression programs; mbIL15, a gene that enhances functional characteristics of immune cells; Sleeping Beauty, a non-viral transposon/transposase system; AttSite recombinases, which breaks and rejoins DNA at specific sequences; AdenoVerse technology platform, a library of engineered adenovector serotypes; and L. lactis is a food-grade bacterium. Additionally, it provides RheoSwitch, an inducible gene switch system that provides quantitative dose-proportionate regulation of the amount and timing of target protein expression; kill switches to selectively eliminate cell therapies in vivo; tissue-specific promoters; UltraCAR-T platform for the treatment of cancer; AdenoVerse Immunotherapy, a library of proprietary adenovectors for the gene delivery; and ActoBiotics platform, genetically modified bacteria that deliver proteins and peptides at mucosal sites. Precigen, Inc. has collaboration and license agreements with Alaunos Therapeutics, Inc.; Ares Trading S.A.; Oragenics, Inc.; Castle Creek Biosciences, Inc.; Intrexon Energy Partners, LLC; and Intrexon Energy Partners II, LLC. The company was formerly known as Intrexon Corporation and changed its name to Precigen, Inc. in January 2020. Precigen, Inc. was founded in 1998 and is based in Germantown, Maryland.

PGEN logo
PGEN
Precigen, Inc.
$3.1

Jeffrey Thomas Perez insider trading

Precigen, Inc.

Mr. Jeffrey Thomas Perez has made 20 insider trades between 2016-2024, according to the Form 4 filled with the SEC.

The largest trade he's ever made was exercising 175,000 units of PGEN stock on 15 May 2020. As of 5 Apr 2024 he still owns at least 458,903 units of PGEN stock.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Units 142,857 N/A N/A
Option
Common Stock 142,857 N/A N/A
Sale
Common Stock 8,891 $1.64 $14,581
Option
Common Stock 18,878 N/A N/A
Option
Restricted Stock Unit 18,878 N/A N/A
Sale
Common Stock 8,741 $1.55 $13,549
Option
Common Stock 18,878 N/A N/A
Option
Restricted Stock Unit 18,878 N/A N/A
Sale
Common Stock 8,956 $1.21 $10,837
Option
Common Stock 18,878 N/A N/A
Option
Restricted Stock Unit 18,878 N/A N/A
Sale
Common Stock 8,789 $1.2 $10,547
Option
Common Stock 18,878 N/A N/A
Option
Restricted Stock Unit 18,878 N/A N/A
Option
Common Stock 37,756 N/A N/A
Option
Restricted Stock Units 37,756 N/A N/A
Purchase
Common Stock 28,571 $1.75 $49,999
Option
Common Stock 18,939 N/A N/A
Option
Restricted Stock Units 18,939 N/A N/A
Option
Restricted Stock Units 31,818 N/A N/A
Sale
Common Stock 14,778 $1.28 $18,916
Option
Common Stock 31,818 N/A N/A
Sale
Common Stock 9,738 $3.59 $34,959
Option
Restricted Stock Units 18,939 N/A N/A
Option
Common Stock 18,939 N/A N/A
Sale
Common Stock 5,022 $3.67 $18,431
Option
Restricted Stock Units 9,765 N/A N/A
Option
Common Stock 9,765 N/A N/A
Option
Common Stock 22,697 N/A N/A
Option
Restricted Stock Units 22,697 N/A N/A
Sale
Common Stock 9,049 $10.57 $95,603
Option
Common Stock 18,940 N/A N/A
Sale
Common Stock 4,951 $10.16 $50,302
Option
Restricted Stock Units 18,940 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Option
Common Stock 9,766 N/A N/A
Sale
Common Stock 9,382 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 7,660 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 7,619 N/A N/A
Option
Restricted Stock Units 25,000 N/A N/A
Option
Common Stock 25,000 N/A N/A
Sale
Common Stock 56,853 N/A N/A
Option
Restricted Stock Units 175,000 N/A N/A
Option
Common Stock 175,000 N/A N/A
Sale
Common Stock 4,927 N/A N/A
Option
Restricted Stock Units 14,340 N/A N/A
Option
Common Stock 14,340 N/A N/A
Sale
Common Stock 6,533 N/A N/A
Option
Common Stock 18,940 N/A N/A
Option
Restricted Stock Units 18,940 N/A N/A
Sale
Common Stock 3,564 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Option
Common Stock 9,766 N/A N/A
Sale
Common Stock 4,366 N/A N/A
Option
Restricted Stock Units 14,340 N/A N/A
Option
Common Stock 14,340 N/A N/A
Sale
Common Stock 4,521 N/A N/A
Option
Common Stock 14,341 N/A N/A
Option
Restricted Stock Units 14,341 N/A N/A
Sale
Common Stock 4,359 N/A N/A
Option
Common Stock 14,341 N/A N/A
Option
Restricted Stock Units 14,341 N/A N/A
Sale
Common Stock 3,514 N/A N/A
Option
Common Stock 9,766 N/A N/A
Option
Restricted Stock Units 9,766 N/A N/A
Purchase
Common Stock 1,000 N/A N/A
Option
Common Stock 5,101 N/A N/A
Option
Option to Purchase Common Stock (Right to Buy) 5,101 N/A N/A

Precigen key executives

Precigen, Inc. executives and other stock owners filed with the SEC:

  • Dr. Helen Sabzevari MPH, Ph.D. (63) Pres, Chief Executive Officer & Director
  • Mr. Donald P. Lehr (50) Chief Legal Officer & Corporation Sec.
  • Mr. Jeffrey Thomas Perez (53) Senior Vice President of Intellectual Property Affairs